Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 1998. Start Trial.
Date Value
October 02, 2026 1.862
October 01, 2026 1.887
September 30, 2026 1.917
September 29, 2026 1.944
September 28, 2026 2.016
September 25, 2026 1.986
September 24, 2026 1.972
September 23, 2026 1.986
September 22, 2026 2.036
September 21, 2026 2.018
September 18, 2026 2.029
September 17, 2026 2.050
September 16, 2026 2.032
September 15, 2026 2.038
September 14, 2026 2.066
September 11, 2026 2.034
September 10, 2026 2.046
September 09, 2026 2.036
September 08, 2026 2.051
September 04, 2026 2.029
September 03, 2026 2.047
September 02, 2026 2.101
September 01, 2026 2.058
August 31, 2026 2.034
August 28, 2026 2.057
Date Value
August 27, 2026 2.032
August 26, 2026 2.114
August 25, 2026 2.086
August 24, 2026 2.080
August 21, 2026 2.123
August 20, 2026 2.080
August 19, 2026 2.072
August 18, 2026 2.103
August 17, 2026 2.093
August 14, 2026 2.096
August 13, 2026 2.064
August 12, 2026 2.148
August 11, 2026 2.070
August 10, 2026 2.016
August 07, 2026 2.088
August 06, 2026 1.965
August 05, 2026 1.871
August 04, 2026 1.912
August 03, 2026 2.021
July 31, 2026 1.880
July 30, 2026 1.762
July 29, 2026 1.576
July 28, 2026 1.477
July 27, 2026 1.464
July 24, 2026 1.457

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Precigen, Inc. 70.16
Repligen Corp. 4.854
Amgen, Inc. 18.64
Biogen, Inc. 1.723
BioMarin Pharmaceutical, Inc. 1.750

Price to Book Value Related Metrics

PS Ratio 2.230
Price to Free Cash Flow 478.66
Price 19.10
Earnings Yield -1.44%
Market Cap 255.62M